Abortion Rights

Virginia District Court Rules FDA Unlawfully Restricted Abortion Pill Access

A Virginia district court judge ordered the FDA to reconsider its restrictions on mifepristone, a highly safe and effective prescription medication for terminating early pregnancy. The judge, Robert S. Ballou, sided with reproductive health clinics in three states that argued that current restrictions are excessive, medically unnecessary, and inconsistent with federal law. The challenged restrictions are part of FDA’s 2023 risk evaluation mitigation strategy (2023 REMS).
Read More

In wide-ranging amicus briefs, experts again urge the Fifth Circuit to reject restrictions on telehealth access to mifepristone

Ahead of oral argument in Louisiana v. U.S. Food and Drug Administration (FDA) on September 9, a wide range of experts — including the American College of Obstetricians and Gynecologists, American College of Emergency Physicians, the National Domestic Violence Hotline, the Disability Rights Education & Defense Fund, the NAACP Legal Defense & Educational Fund, pharmaceutical and biotech manufacturers, and former military officials — are urging the U.S. Court of Appeals for the Fifth Circuit to reject anti-abortion politicians’ effort to end telemedicine and mail and pharmacy access to mifepristone nationwide.Mifepristone is used in nearly two-thirds of U.S. abortions, with more than 1 in 4 patients
Read More

New Battleground Poll: Todd Blanche’s Anti-Abortion Record is Toxic for Congressional Republicans Ahead of Critical Midterms

New battleground polling conducted by Reproductive Freedom for All and Public Policy Polling shows that Todd Blanche’s threats to use the Department of Justice (DOJ) to restrict abortion access are deeply unpopular and could create serious political consequences for congressional Republicans in November.
Read More

Reproductive Freedom for All Condemns Senate Confirmation of Erica Schwartz as CDC Director

The U.S. Senate confirmed Erica Schwartz to lead the Centers for Disease Control and Prevention (CDC), despite her dangerous commitment to undermine abortion access and patients’ data privacy. During her confirmation hearing, Schwartz said abortion surveillance is “absolutely a critical component” of the CDC’s work and signaled the federal government could explore collecting more sensitive abortion data. 
Read More
No widgets found. Go to Widget page and add the widget in Offcanvas Sidebar Widget Area.